{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:22:54Z","timestamp":1790043774638,"version":"4.0.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T00:00:00Z","timestamp":1254873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0007320","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T19:41:14Z","timestamp":1254858074000},"page":"e7320","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["In Vivo and Ex Vivo Evaluation of L-Type Calcium Channel Blockers on Acid \u03b2-Glucosidase in Gaucher Disease Mouse Models"],"prefix":"10.1371","volume":"4","author":[{"given":"Ying","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"key":"ref1","first-page":"3635","article-title":"Gaucher Disease.","author":"E Beutler","year":"2001"},{"key":"ref2","article-title":"Gaucher disease: Phenotypic and genetic variation. Chapter 146.1.","author":"GA Grabowski","year":"2006"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/oxfordjournals.jbchem.a122457","article-title":"Intracellular transport of acid alpha-glucosidase in human fibroblasts: evidence for involvement of phosphomannosyl receptor-independent system.","volume":"104","author":"A Tsuji","year":"1988","journal-title":"J Biochem (Tokyo)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.","volume":"160","author":"J Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-1119(90)90264-R","article-title":"Prevalent and rare mutations among Gaucher patients.","volume":"96","author":"N Eyal","year":"1990","journal-title":"Gene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/bmme.1996.0077","article-title":"The glucocerebrosidase D409H mutation in Gaucher disease.","volume":"59","author":"M Pasmanik-Chor","year":"1996","journal-title":"Biochem Mol Med"},{"key":"ref7","first-page":"212","article-title":"Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.","volume":"45","author":"B Theophilus","year":"1989","journal-title":"Am J Hum Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease.","volume":"163","author":"YH Xu","year":"2003","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.","volume":"113","author":"NJ Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.20504","article-title":"Guidance on the use of miglustat for treating patients with type 1 Gaucher disease.","volume":"80","author":"NJ Weinreb","year":"2005","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","article-title":"Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.","volume":"15","author":"TD Butters","year":"2005","journal-title":"Glycobiology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.pbio.0060026","article-title":"Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis.","volume":"6","author":"TW Mu","year":"2008","journal-title":"PLoS Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.","volume":"3","author":"RL Lieberman","year":"2007","journal-title":"Nat Chem Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ymgme.2008.12.008","article-title":"Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells.","volume":"96","author":"B Rigat","year":"2009","journal-title":"Mol Genet Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1267\/ahc.07002","article-title":"Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena.","volume":"40","author":"V Zinchuk","year":"2007","journal-title":"Acta Histochem Cytochem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1615\/JEnvironPatholToxicolOncol.v26.i3.30","article-title":"Protective effect of diltiazem (a calcium channel blocker) against cadmium-induced toxicity in mice.","volume":"26","author":"V Nunia","year":"2007","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"ref17","first-page":"672","article-title":"Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model.","volume":"59","author":"JJ Luszczki","year":"2007","journal-title":"Pharmacol Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004670000480","article-title":"Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension.","volume":"15","author":"JT Flynn","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation.","volume":"278","author":"Y Sun","year":"2003","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"25259","DOI":"10.1074\/jbc.M701614200","article-title":"Reconstitution and characterization of a nicotinic acid adenine dinucleotide phosphate (NAADP)-sensitive Ca2+ release channel from liver lysosomes of rats.","volume":"282","author":"F Zhang","year":"2007","journal-title":"J Biol Chem"},{"key":"ref21","first-page":"25","article-title":"Penetration into and elimination from the cerebrospinal fluid of diltiazem, a calcium antagonist, in anesthetized rabbits.","volume":"36","author":"K Naito","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejheart.2005.07.012","article-title":"Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy.","volume":"8","author":"D Westermann","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"ref23","first-page":"327","article-title":"Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents.","volume":"55","author":"G Biala","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.","volume":"99","author":"AR Sawkar","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.","volume":"103","author":"RA Steet","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/cbic.200800249","article-title":"Isofagomine induced stabilization of glucocerebrosidase.","volume":"9","author":"GJ Kornhaber","year":"2008","journal-title":"Chembiochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"C327","DOI":"10.1152\/ajpcell.1998.275.2.C327","article-title":"Ion channels in microglia (brain macrophages).","volume":"275","author":"C Eder","year":"1998","journal-title":"Am J Physiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure.","volume":"95","author":"Y Liu","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2006.09.008","article-title":"Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease.","volume":"90","author":"GB Sinclair","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease.","volume":"104","author":"IB Enquist","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/hmg\/ddm040","article-title":"Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.","volume":"16","author":"Y Sun","year":"2007","journal-title":"Hum Mol Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0007320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:31:24Z","timestamp":1558560684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0007320"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0007320","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,7]]}}}